Metastatic renal cancer: better never than late

Affiliations

¹ Division of Hematology and Medical Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA. Electronic address: Matthew.galsky@mssm.edu.

Editorial

Matthew D Galsky. Eur Urol. 2014 Jun.

. 2014 Jun;65(6):1093-4.

doi: 10.1016/j.eururo.2013.08.004. Epub 2013 Aug 9.

¹ Division of Hematology and Medical Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA. Electronic address: Matthew.galsky@mssm.edu.

No abstract available

Comment on

Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy.
Kroeger N, Choueiri TK, Lee JL, Bjarnason GA, Knox JJ, MacKenzie MJ, Wood L, Srinivas S, Vaishamayan UN, Rha SY, Pal SK, Yuasa T, Donskov F, Agarwal N, Tan MH, Bamias A, Kollmannsberger CK, North SA, Rini BI, Heng DY. Kroeger N, et al. Eur Urol. 2014 Jun;65(6):1086-92. doi: 10.1016/j.eururo.2013.07.031. Epub 2013 Jul 30. Eur Urol. 2014. PMID: 23916693